Guben Kechuan granule attenuates bronchial asthma by inhibiting NF-κB/STAT3 signaling pathway-mediated apoptosis

Chronic asthma caused by allergies is a lung illness marked by airway remodeling and hyperresponsiveness. Guben Kechuan (GK) granule is a clinically proven formula for treating lung disease. It relieves cough and helps to clear phlegm, but the mechanisms underlying its treatment for asthma are not c...

Full description

Saved in:
Bibliographic Details
Published inJournal of ethnopharmacology Vol. 340; p. 119124
Main Authors Dai, Chuanhao, Liu, Dewen, Qin, Cuiying, Fang, Jingya, Cheng, Guangqing, Xu, Chunhong, Wang, Qixin, Lu, Tianming, Guo, Zuchang, Wang, Jigang, Zhong, Tianyu, Guo, Qiuyan
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 31.01.2025
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Chronic asthma caused by allergies is a lung illness marked by airway remodeling and hyperresponsiveness. Guben Kechuan (GK) granule is a clinically proven formula for treating lung disease. It relieves cough and helps to clear phlegm, but the mechanisms underlying its treatment for asthma are not clear. We aimed to elucidate the efficacy and potential mechanisms by which GK ameliorates allergic asthma. Ultra-performance liquid chromatography (UHPLC-LTQ-Orbitrap-MS) identified the main chemical components of GK. The efficacy of GK was studied in an ovalbumin/alum (OVA)/AL(OH)3-sensitized rat model of bronchial asthma by measuring cytokine concentrations in serum and alveolar lavage samples, examining tissue pathology, and performing leukocyte counts. The mechanisms underlying its effectiveness in asthma were investigated by both transcriptomic and proteomic analyses. GK relieved asthma-induced airway inflammation and remodeling, reduced inflammatory cell infiltration, and decreased the levels of the inflammatory cytokines TNF-α, IL-4, IL-5, IL-6, and IL-10. Analysis of the transcriptomic and proteomic results found that asthma activated the transcription factors STAT3 and NF-κB and induced oxidative-stress damage and apoptosis. GK was found to reduce Bax and caspase-3 expression, increase Bcl-2 expression, and inhibit asthma-induced apoptosis. GK downregulated the expression of the transcription factors STAT3 and NF-kB, which decreased the inflammatory response. Decreases in CAT, SOD, and GSH reduced asthma-induced oxidative-stress damage. Our findings provide evidence that GK alleviates bronchial asthma by inhibiting apoptosis and oxidative stress damage mediated by the NF-κB/STAT3 signaling pathway. [Display omitted] •GK alleviates airway remodeling and hyperresponsiveness in allergic asthma.•GK reduces inflammatory factor levels in serum and BALF and leukocyte counts in BALF of rats with allergic asthma.•GK inhibits the NF-κB/STAT3 signaling pathway and attenuates oxidative stress and apoptosis caused by allergic asthma.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0378-8741
1872-7573
1872-7573
DOI:10.1016/j.jep.2024.119124